Launch before the second half of 2016. What savings program will be offered?
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
25 readers recommended
Flat insulin allows for flexible dosing with lower likelihood of hypoglycemia. How is it priced vs. Levemir?
23 readers recommended
Smartphone user interface with no screen or buttons on the pump! Launch: 2018?
26 readers recommended
IBM and Medtronic announce the first product out of their innovative partnership.
22 readers recommended
Goal to maintain access to therapy over next six months. What challenges have been seen to date?
38 readers recommended
Will this drug be cheaper than Lantus and other insulins?
24 readers recommended
What were the risks and benefits of this drug?
26 readers recommended
New trial aims to make U500 (more concentrated) insulin easier to take.
16 readers recommended
My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”
27 readers recommended
How safe and effective is Jardiance in people with type 1 diabetes?
38 readers recommended
Plus, why this drug may also be heart healthy.
33 readers recommended
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
26 readers recommended
New trial testing the inhaled, ultra-rapid insulin in 4-17 year olds.
17 readers recommended
When might this product reach the market?
26 readers recommended
Breaking news from Stockholm, Sweden, where our team is on the ground at the European Association for the Study of Diabetes (EASD) Conference – one of the largest...
31 readers recommended
Clinical trial currently enrolling for type 2 diabetes – find out if you qualify for this study.
42 readers recommended
Combining metformin and Jardiance into a single pill.
12 readers recommended
Approved for those who can’t tolerate more statins – is this you?
28 readers recommended
Plus, a massive $2 billion investment in new production facilities!
24 readers recommended
Why the company decided against pursuing its type 2 GLP-1 drug Victoza to the FDA for use in type 1 diabetes.